Latest research
A random sample from the latest fetch — today's curated picks have not been contributed yet. Contribute today's picks →
- From the Frontlines at WPC 2026: Wilma van de Berg, PhD talks with WPC 2026 Reporter Monique Bosman ▶ video
- From the Frontlines at WPC 2026: Roberta Marongiu, PhD with Mattia Volta, PhD (Italian) ▶ video
- DBSsync: combining intracranial and multimodal data to investigate new biomarkers in Parkinson’s disease
- A convergent metabolic-kinase signaling axis links Parkinson s disease and multiple system atrophy
- From the Front Lines at WPC 2026: Robin Elliott ▶ video
- Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?
See more ↓See less ↑
News, foundations & community
A random sample from the latest fetch — today's curated picks have not been contributed yet. Contribute today's picks →
- Nueva oportunidad terapéutica en párkinson: mejor capacidad para caminar - Redacción Médica
- Carine Crutzen over vader met dementie: 'Dat iets simpels als optellen niet meer lukte vond hij verschrikkelijk' - LINDA.nl
- 20/06/2026 | Vacinação HPV, Parkinson e alertas clínicos - Afya | Home
- Repas caritatif – Entente Bichoise – Comité 58
- Irán avanza en estimulación cerebral para el párkinson con posibilidad de ensayos en humanos para 2027 - TV BRICS
- Perdre l'odorat ou le goût : une étude révèle un impact aussi grave sur la vie que le diabète ou Parkinson. - Top Santé
See more ↓See less ↑
Digests
Week 24, 2026 (8–14 Jun)
No digest yet. Write it →
May 2026
See past digests (5) ↓Hide past digests ↑
Recent reader summaries
- Exercise and smoking: health rivals revealing shared protective mechanisms in Parkinson’s?
- Levodopa increases substantia nigra iron: implications for Parkinson's disease
- Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson’s disease
- Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson’s disease
- Observations on an Open‐Label Phase 1/2 Dopamine Gene Therapy Trial (OXB‐102/Axo‐Lenti‐PD) in People with Parkinson's Disease
- The Place of Adaptive Deep Brain Stimulation in Parkinson's Disease: Spatial before Temporal Optimization